Preferred Label : nilemdo;
Origin ID : M000736626;
Related record
https://www.has-sante.fr/jcms/p_3594378/fr/nilemdo-acide-bempedoique-dyslipidemie
2025
false
false
false
France
adult
risk
treatment outcome
insurance, health, reimbursement
bempedoic acid
nilemdo
Heart Disease Risk Factors
primary prevention
secondary prevention
cardiovascular diseases
Atherosclerotic Cardiovascular Disease
administration, oral
Product containing precisely bempedoic acid 180 milligram/1 each conventional release
oral tablet (clinical drug)
evaluation of the transparency committee
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
hypercholesterolemia
---
